These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1684392)

  • 1. Monoaminergic regulation of brain somatostatin metabolism in rats.
    Maeda K; Kakigi T; Kawata E; Kaneda H
    Jpn J Psychiatry Neurol; 1991 Mar; 45(1):109-10. PubMed ID: 1684392
    [No Abstract]   [Full Text] [Related]  

  • 2. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
    Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Functional role of transmitter systems in the brain].
    Guldberg HC
    Tidsskr Nor Laegeforen; 1973 Jun; 93(17):1305-9. PubMed ID: 4148047
    [No Abstract]   [Full Text] [Related]  

  • 4. A role of some central neurotransmitter systems in the mechanism of electroconvulsive shock action.
    Kleinrok Z; Wielosz M
    Pol J Pharmacol Pharm; 1985; 37(6):745-52. PubMed ID: 3008135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin: a mediator of the brain-gut connection.
    Kim DY; Camilleri M
    Am J Gastroenterol; 2000 Oct; 95(10):2698-709. PubMed ID: 11051338
    [No Abstract]   [Full Text] [Related]  

  • 6. Thirty years of dopamine research.
    Carlsson A
    Adv Neurol; 1993; 60():1-10. PubMed ID: 8093570
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interaction of neurotransmitters in specific circuits of the brain].
    Mora Teruel F
    An R Acad Nac Med (Madr); 1998; 115(3):653-7; discussion 657-8. PubMed ID: 10208018
    [No Abstract]   [Full Text] [Related]  

  • 8. Tetrahydrobiopterin and dopamine release.
    Watanabe Y; Mataga N; Imamura K; Onoe H; Koshimura K; Miwa S; Hartvig P; Tedroff J; Bjurling P; Långström B
    Jpn J Psychiatry Neurol; 1991 Jun; 45(2):513-4. PubMed ID: 1684829
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopaminergic activation of Fos and the rat model of Parkinson's disease.
    Cole DG
    Adv Neurol; 1993; 60():334-7. PubMed ID: 8380526
    [No Abstract]   [Full Text] [Related]  

  • 10. Developmental pharmacodynamics: implications for child and adolescent psychopharmacology.
    Carrey N; Kutcher S
    J Psychiatry Neurosci; 1998 Nov; 23(5):274-6. PubMed ID: 9846031
    [No Abstract]   [Full Text] [Related]  

  • 11. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.
    Miczek KA; Fish EW; De Bold JF; De Almeida RM
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):434-58. PubMed ID: 12373445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurochemical aspects of the emotional reactivity and motor activity of rats in new circumstances].
    Kulagin DA; Bolondinskiĭ VK
    Usp Fiziol Nauk; 1986; 17(1):92-109. PubMed ID: 2420084
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo modulatory action of extracellular glutamate on the anticonvulsant effects of hippocampal dopamine and serotonin.
    Clinckers R; Gheuens S; Smolders I; Meurs A; Ebinger G; Michotte Y
    Epilepsia; 2005 Jun; 46(6):828-36. PubMed ID: 15946324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The interaction of the serotonin and dopaminergic systems of the brain in the mechanisms of latent inhibition in rats].
    Loskutova LV; Luk'ianenko FIa; Il'iuchenok RIu
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1989; 39(4):714-20. PubMed ID: 2816057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monoaminergic synapses in the brain--regulation and ontogenetic development].
    Nomura Y
    Yakugaku Zasshi; 1982 Jul; 102(7):603-16. PubMed ID: 6296351
    [No Abstract]   [Full Text] [Related]  

  • 16. [The central nature of the interaction of neuromediator systems in immunomodulation].
    Al'perina EL; Idova GV
    Fiziol Zh SSSR Im I M Sechenova; 1990 Apr; 76(4):453-8. PubMed ID: 2170172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states.
    Millan MJ; Newman-Tancredi A; Audinot V; Cussac D; Lejeune F; Nicolas JP; Cogé F; Galizzi JP; Boutin JA; Rivet JM; Dekeyne A; Gobert A
    Synapse; 2000 Feb; 35(2):79-95. PubMed ID: 10611634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroleptics and serotonin].
    Hery F; Hamon M
    Encephale; 1993; 19(5):525-32. PubMed ID: 7905821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin in animal models of alcoholism.
    Compagnon P; Ernouf D; Narcisse G; Daoust M
    Alcohol Alcohol Suppl; 1993; 2():215-9. PubMed ID: 7748303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of MAO in dopaminergic transmission.
    Riederer P; Konradi C; Youdim MB
    Adv Neurol; 1990; 53():149-53. PubMed ID: 2173368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.